Bone marrow acid phosphatase concentrations in individuals with prostatic carcinoma or other disorders.

Can Med Assoc J. 1978 August 12; 119(3): 259–261.

PMCID: PMC1818165

C. Little, A. M. Shojania, P. T. Green, and B. H. Weinerman

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (490K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

259

261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Reynolds, RD; Greenberg, BR; Martin, ND; Lucas, RN; Gaffney, CN; Hawn, L. Usefulness of bone marrow serum acid phosphatase in staging carcinoma of the prostate. Cancer. 1973 Jul;32(1):181–184. [PubMed]
Yarrison, G; Mertens, BF; Mathies, JC. New diagnostic use of bone marrow acid and alkaline phosphatase. Am J Clin Pathol. 1976 Oct;66(4):667–671. [PubMed]
Pontes, JE; Alcorn, SW; Thomas, AJ, Jr; Pierce, JM., Jr Bone marrow acid phosphatase in staging prostatic carcinoma. J Urol. 1975 Sep;114(3):422–424. [PubMed]
Veenema, RJ; Gursel, EO; Romas, N; Wechsler, M; Lattimer, JK. Bone marrow acid phosphatase: prognostic value in patients undergoing radical prostatectomy. J Urol. 1977 Jan;117(1):81–82. [PubMed]
Roy, AV; Brower, ME; Hayden, JE. Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum. Clin Chem. 1971 Nov;17(11):1093–1102. [PubMed]